140 related articles for article (PubMed ID: 35817555)
1. Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities.
Ho SWT; Sheng T; Xing M; Ooi WF; Xu C; Sundar R; Huang KK; Li Z; Kumar V; Ramnarayanan K; Zhu F; Srivastava S; Isa ZFBA; Anene-Nzelu CG; Razavi-Mohseni M; Shigaki D; Ma H; Tan ALK; Ong X; Lee MH; Tay ST; Guo YA; Huang W; Li S; Beer MA; Foo RSY; Teh M; Skanderup AJ; Teh BT; Tan P
Gut; 2023 Feb; 72(2):226-241. PubMed ID: 35817555
[TBL] [Abstract][Full Text] [Related]
2. Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer.
Sheng T; Ho SWT; Ooi WF; Xu C; Xing M; Padmanabhan N; Huang KK; Ma L; Ray M; Guo YA; Sim NL; Anene-Nzelu CG; Chang MM; Razavi-Mohseni M; Beer MA; Foo RSY; Sundar R; Chan YH; Tan ALK; Ong X; Skanderup AJ; White KP; Jha S; Tan P
Genome Med; 2021 Oct; 13(1):158. PubMed ID: 34635154
[TBL] [Abstract][Full Text] [Related]
3. Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent
Ooi WF; Nargund AM; Lim KJ; Zhang S; Xing M; Mandoli A; Lim JQ; Ho SWT; Guo Y; Yao X; Lin SJ; Nandi T; Xu C; Ong X; Lee M; Tan AL; Lam YN; Teo JX; Kaneda A; White KP; Lim WK; Rozen SG; Teh BT; Li S; Skanderup AJ; Tan P
Gut; 2020 Jun; 69(6):1039-1052. PubMed ID: 31542774
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive molecular phenotyping of
Xu C; Huang KK; Law JH; Chua JS; Sheng T; Flores NM; Pizzi MP; Okabe A; Tan ALK; Zhu F; Kumar V; Lu X; Benitez AM; Lian BSX; Ma H; Ho SWT; Ramnarayanan K; Anene-Nzelu CG; Razavi-Mohseni M; Abdul Ghani SAB; Tay ST; Ong X; Lee MH; Guo YA; Ashktorab H; Smoot D; Li S; Skanderup AJ; Beer MA; Foo RSY; Wong JSH; Sanghvi K; Yong WP; Sundar R; Kaneda A; Prabhakar S; Mazur PK; Ajani JA; Yeoh KG; So JB; Tan P;
Gut; 2023 Sep; 72(9):1651-1663. PubMed ID: 36918265
[TBL] [Abstract][Full Text] [Related]
5. Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity.
Ooi WF; Xing M; Xu C; Yao X; Ramlee MK; Lim MC; Cao F; Lim K; Babu D; Poon LF; Lin Suling J; Qamra A; Irwanto A; Qu Zhengzhong J; Nandi T; Lee-Lim AP; Chan YS; Tay ST; Lee MH; Davies JO; Wong WK; Soo KC; Chan WH; Ong HS; Chow P; Wong CY; Rha SY; Liu J; Hillmer AM; Hughes JR; Rozen S; Teh BT; Fullwood MJ; Li S; Tan P
Nat Commun; 2016 Sep; 7():12983. PubMed ID: 27677335
[TBL] [Abstract][Full Text] [Related]
6. Specific chromatin landscapes and transcription factors couple breast cancer subtype with metastatic relapse to lung or brain.
Cai WL; Greer CB; Chen JF; Arnal-Estapé A; Cao J; Yan Q; Nguyen DX
BMC Med Genomics; 2020 Mar; 13(1):33. PubMed ID: 32143622
[TBL] [Abstract][Full Text] [Related]
7. Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer.
Ivanova T; Zouridis H; Wu Y; Cheng LL; Tan IB; Gopalakrishnan V; Ooi CH; Lee J; Qin L; Wu J; Lee M; Rha SY; Huang D; Liem N; Yeoh KG; Yong WP; Teh BT; Tan P
Gut; 2013 Jan; 62(1):22-33. PubMed ID: 22535375
[TBL] [Abstract][Full Text] [Related]
8. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
[TBL] [Abstract][Full Text] [Related]
9. The hyper-activation of transcriptional enhancers in breast cancer.
Li QL; Wang DY; Ju LG; Yao J; Gao C; Lei PJ; Li LY; Zhao XL; Wu M
Clin Epigenetics; 2019 Mar; 11(1):48. PubMed ID: 30867030
[TBL] [Abstract][Full Text] [Related]
10. Epigenomic features revealed by ATAC-seq impact transgene expression in CHO cells.
Lee Z; Raabe M; Hu WS
Biotechnol Bioeng; 2021 May; 118(5):1851-1861. PubMed ID: 33521928
[TBL] [Abstract][Full Text] [Related]
11.
Xu C; Ooi WF; Qamra A; Tan J; Chua BY; Ho SWT; Das K; Adam Isa ZF; Li Z; Yao X; Yan T; Xing M; Huang KK; Lin JS; Nandi T; Tay ST; Lee MH; Tan ALK; Ong X; Ashktorab H; Smoot D; Li S; Ng SC; Teh BT; Tan P
Gut; 2020 Feb; 69(2):231-242. PubMed ID: 31068366
[TBL] [Abstract][Full Text] [Related]
12. Multi-omic profiling of peritoneal metastases in gastric cancer identifies molecular subtypes and therapeutic vulnerabilities.
Tanaka Y; Chiwaki F; Kojima S; Kawazu M; Komatsu M; Ueno T; Inoue S; Sekine S; Matsusaki K; Matsushita H; Boku N; Kanai Y; Yatabe Y; Sasaki H; Mano H
Nat Cancer; 2021 Sep; 2(9):962-977. PubMed ID: 35121863
[TBL] [Abstract][Full Text] [Related]
13. Super-enhancers: Implications in gastric cancer.
Huang Y; Huo Y; Huang L; Zhang L; Zheng Y; Zhang N; Yang M
Mutat Res Rev Mutat Res; 2024; 793():108489. PubMed ID: 38355091
[TBL] [Abstract][Full Text] [Related]
14. ATAC-Seq Reveals an
Galang G; Mandla R; Ruan H; Jung C; Sinha T; Stone NR; Wu RS; Mannion BJ; Allu PKR; Chang K; Rammohan A; Shi MB; Pennacchio LA; Black BL; Vedantham V
Circ Res; 2020 Dec; 127(12):1502-1518. PubMed ID: 33044128
[TBL] [Abstract][Full Text] [Related]
15. Regulatory crosstalk between lineage-survival oncogenes KLF5, GATA4 and GATA6 cooperatively promotes gastric cancer development.
Chia NY; Deng N; Das K; Huang D; Hu L; Zhu Y; Lim KH; Lee MH; Wu J; Sam XX; Tan GS; Wan WK; Yu W; Gan A; Tan AL; Tay ST; Soo KC; Wong WK; Dominguez LT; Ng HH; Rozen S; Goh LK; Teh BT; Tan P
Gut; 2015 May; 64(5):707-19. PubMed ID: 25053715
[TBL] [Abstract][Full Text] [Related]
16. Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil.
Lei Z; Tan IB; Das K; Deng N; Zouridis H; Pattison S; Chua C; Feng Z; Guan YK; Ooi CH; Ivanova T; Zhang S; Lee M; Wu J; Ngo A; Manesh S; Tan E; Teh BT; So JB; Goh LK; Boussioutas A; Lim TK; Flotow H; Tan P; Rozen SG
Gastroenterology; 2013 Sep; 145(3):554-65. PubMed ID: 23684942
[TBL] [Abstract][Full Text] [Related]
17. Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networks.
Neyret-Kahn H; Fontugne J; Meng XY; Groeneveld CS; Cabel L; Ye T; Guyon E; Krucker C; Dufour F; Chapeaublanc E; Rapinat A; Jeffery D; Tanguy L; Dixon V; Neuzillet Y; Lebret T; Gentien D; Davidson I; Allory Y; Bernard-Pierrot I; Radvanyi F
Oncogene; 2023 May; 42(19):1524-1542. PubMed ID: 36944729
[TBL] [Abstract][Full Text] [Related]
18. Opening up the blackbox: an interpretable deep neural network-based classifier for cell-type specific enhancer predictions.
Kim SG; Theera-Ampornpunt N; Fang CH; Harwani M; Grama A; Chaterji S
BMC Syst Biol; 2016 Aug; 10 Suppl 2(Suppl 2):54. PubMed ID: 27490187
[TBL] [Abstract][Full Text] [Related]
19. Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling.
Huang H; Hu J; Maryam A; Huang Q; Zhang Y; Ramakrishnan S; Li J; Ma H; Ma VWS; Cheuk W; So GYK; Wang W; Cho WCS; Zhang L; Chan KM; Wang X; Chin YR
Nat Commun; 2021 Apr; 12(1):2242. PubMed ID: 33854062
[TBL] [Abstract][Full Text] [Related]
20. Non-coding somatic mutations converge on the PAX8 pathway in ovarian cancer.
Corona RI; Seo JH; Lin X; Hazelett DJ; Reddy J; Fonseca MAS; Abassi F; Lin YG; Mhawech-Fauceglia PY; Shah SP; Huntsman DG; Gusev A; Karlan BY; Berman BP; Freedman ML; Gayther SA; Lawrenson K
Nat Commun; 2020 Apr; 11(1):2020. PubMed ID: 32332753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
